These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31740880)

  • 1. WNT signalling pathway in oral lesions.
    Ejaz I; Ghafoor S
    J Pak Med Assoc; 2019 Nov; 69(11):1687-1692. PubMed ID: 31740880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-Catenin Signaling in Oral Carcinogenesis.
    Reyes M; Flores T; Betancur D; Peña-Oyarzún D; Torres VA
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dickkopf-1 may regulate bone coupling by attenuating wnt/β-catenin signaling in chronic apical periodontitis.
    Tan X; Huang D; Zhou W; Yan L; Yue J; Lu W; Song D; Zhou X; Ye L; Zhang L
    Arch Oral Biol; 2018 Feb; 86():94-100. PubMed ID: 29216526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in oral and maxillofacial diseases.
    Zhang Z; Pan X; Chen M; Bai M
    Cell Biol Int; 2022 Jan; 46(1):34-45. PubMed ID: 34643311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible role for the WNT-1 pathway in oral carcinogenesis.
    Lo Muzio L
    Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Wnt/β-catenin signaling attenuates periapical bone lesions.
    Tang Y; Zhou X; Gao B; Xu X; Sun J; Cheng L; Zhou X; Zheng L
    J Dent Res; 2014 Feb; 93(2):175-82. PubMed ID: 24211867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potentially malignant disorders of the oral mucosa: terminology and classification].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt/β-catenin signaling pathway has a healing ability for periapical periodontitis.
    Naruse H; Itoh S; Itoh Y; Kagioka T; Abe M; Hayashi M
    Sci Rep; 2021 Oct; 11(1):19673. PubMed ID: 34608236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Wnt Signaling in Squamous Cell Carcinoma.
    Shiah SG; Shieh YS; Chang JY
    J Dent Res; 2016 Feb; 95(2):129-34. PubMed ID: 26516128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
    Vidya Priyadarsini R; Senthil Murugan R; Nagini S
    Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway.
    Liu N; Shi S; Deng M; Tang L; Zhang G; Liu N; Ding B; Liu W; Liu Y; Shi H; Liu L; Jin Y
    J Bone Miner Res; 2011 Sep; 26(9):2082-95. PubMed ID: 21638320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentially malignant disorders of the oral mucosa].
    Ben Slama L
    Rev Prat; 2019 Oct; 69(8):856-860. PubMed ID: 32237647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
    Rai B; Kaur J; Jacobs R; Singh J
    J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia.
    Scully C
    Oral Dis; 2014 Jan; 20(1):1-5. PubMed ID: 24320967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
    Vallée A; Lecarpentier Y
    Front Immunol; 2018; 9():745. PubMed ID: 29706964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling in bone marrow niche.
    Ahmadzadeh A; Norozi F; Shahrabi S; Shahjahani M; Saki N
    Cell Tissue Res; 2016 Feb; 363(2):321-35. PubMed ID: 26475718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management update of potentially premalignant oral epithelial lesions.
    Awadallah M; Idle M; Patel K; Kademani D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):628-636. PubMed ID: 29656948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.